X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217961
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-presents-positive-results-from-pivotal-phase-3-boundless-trial-of-investigational-nd0612-in-people-with-parkinsons-disease-experiencing-motor-fluctuations-301911810.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215999
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208895
https://health.economictimes.indiatimes.com/news/pharma/us-fda-declines-to-approve-abbvies-parkinsons-disease-therapy/98931024
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216537
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216505
https://www.prnewswire.com/news-releases/beyond-phase-2b-data-indicates-nd0612-has-a-positive-long-term-safety-profile-for-people-with-parkinsons-disease-301516232.html
https://www.prnewswire.com/news-releases/avion-pharmaceuticals-llc-an-alora-pharmaceuticals-company-announces-the-fda-approval-and-availability-of-dhivytm-for-the-treatment-of-parkinsons-disease-301481295.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213212
https://www.biospace.com/article/abbvie-eyes-potential-approval-of-parkinson-s-disease-treatment-following-positive-phase-iii-results/?s=71
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214091
http://www.pharmafile.com/news/587415/amneal-s-ipx-203-shows-promising-results-motor-fluctuations-parkinson-s-disease
https://endpts.com/amneal-touts-results-from-phase-iii-trial-on-parkinsons-novarock-partners-on-cancer-drug/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214092
https://www.prnewswire.com/news-releases/abbvie-to-present-new-data-from-18-abstracts-at-the-international-congress-of-parkinsons-disease-and-movement-disorders-301128096.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203424
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210911
https://www.federalregister.gov/documents/2019/12/02/2019-25946/morton-grove-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-21-abbreviated-new-drug
https://www.biospectrumasia.com/news/25/14786/lobsor-pharma-receives-japanese-patent-for-apd-solution.html
https://www.biospectrumasia.com/news/25/14786/lobsor-pharma-receives-japanese-patent-for-apd-solution.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211055
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-corporation-group-announces-presentation-of-patient-reported-results-from-phase-2-nd0612-study-at-international-congress-of-parkinsons-disease-and-movement-disorders-300923267.html
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-hifibio-s-kite-backed-c-round-kyowa-kirin-s-parkinson-s-nod-relief-for
https://www.fda.gov/drugs/drug-safety-and-availability/fda-review-finds-no-increased-risk-prostate-cancer-parkinsons-disease-medicines-containing
https://www.fiercebiotech.com/biotech/intec-flunks-phase-3-parkinson-s-test-against-merck-drug
https://www.biospace.com/article/releases/intec-pharma-announces-results-from-earlier-phase-2-clinical-trial-of-accordion-pill-carbidopa-levodopa-in-advanced-parkinson-s-disease-patients-published-in-parkinsonism-and-related-disorders/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-parkinsons-disease-treatment-drugs/articleshow/69673175.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210341
https://www.businesswire.com/news/home/20181221005620/en/ADDING-MULTIMEDIA-Acorda-Therapeutics-Announces-FDA-Approval
https://www.fiercepharma.com/manufacturing/merck-runs-out-parkinson-s-disease-drug-sinemet-as-manufacturing-issues-unexpected
https://www.fiercebiotech.com/biotech/duke-antidepressant-startup-evecxia-brings-ex-cerecor-chief-as-ceo
https://www.fiercepharma.com/pharma/merck-pledges-price-cuts-and-controls-across-its-portfolio-but-it-s-not-as-benevolent-as-it
https://www.prnewswire.com/news-releases/amneal-announces-patent-litigation-settlement-agreement-with-actavis-concerning-rytary-300669102.html
https://www.pharmacompass.com/pdf/news/rytary-levodopacarbidopa-capsules-impax-lab-v-actavis-laboratories-1527500807.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209910
https://www.prnewswire.com/news-releases/intec-pharma-presented-phase-1-pk-and-safety-data-from-accordion-pill-carbidopalevodopa-at-american-academy-of-neurology-annual-meeting-680656761.html
https://www.biospectrumasia.com/news/25/10563/lupin-brings-generic-lodosyn-tablets-to-us-market.html
https://www.prnewswire.com/news-releases/intec-pharma-partners-with-lts-for-manufacture-of-accordion-pill-carbidopalevodopa-for-treatment-of-parkinsons-disease-676589423.html
http://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=6948286311599320&topic=NTEC&symbology=null&cp=null&webmasterId=101803
https://www.biospectrumasia.com/regulatory/34/10116/intec-pharma-acknowledged-with-patent-.html
https://www.in-pharmatechnologist.com/Article/2018/01/04/Intec-gets-Canadian-patent-for-Accordion-Pill-controlled-release-tech
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204763
https://www.europeanpharmaceuticalreview.com/news/67495/parkinsons-carbidopa-anticancer/
http://www.pharmatimes.com/news/fda_oks_first_novel_treatment_for_parkinsons_in_ten_years_1189668
Market Place
Share 
